DOATS-F Score (Draft)：公開準備中

DOATS score (https://shibatay8.wixsite.com/doats-score--a-simpl/post/doats-score)はSARS-CoV2オミクロン株流下でも重症化リスク評価に有用ではありますが、それ以前の株の流行期に比べて、判別能が低下しております。DOATSスコアに慢性腎臓病、自己免疫性疾患、血液悪性疾患の有無、ワクチン接種回数、寝たきり（要介護状態）であるかどうかの情報を加えることで、DOATSスコアの判別能、較正、臨床的有用性を改善することができます。

Risk Prediction for Exacerbation in Patients with Mild to Moderate COVID-19 (without respiratory failure) based on the DOATS-F Score
The DOATS-f score allows for the stratification of patients with mild to moderate COVID-19 who are at risk of clinical deterioration. The estimated risk of progression is as follows: Less than 3 points: < 2%; 3-5 points: 2.7%; 6-8 points: 5.4%; 9-12 points: 7.9%; 13-16 points: 23.2%; More than 16 points: More than 27.9%